Everolimus is a medication used in the treatment of certain types of cancer, including advanced breast cancer, kidney cancer, and neuroendocrine tumors. It belongs to a class of drugs known as mTOR inhibitors.
Everolimus works by inhibiting a protein called mTOR (mammalian target of rapamycin), which is involved in the growth and division of cancer cells. By blocking mTOR, everolimus helps to slow down or stop the growth of cancer cells and shrink tumors.
The medication is typically taken orally in the form of tablets. The dosage and treatment duration depend on the specific type and stage of cancer being treated, as well as the individual’s overall health.
Common side effects of everolimus may include fatigue, mouth sores, rash, diarrhea, and decreased blood cell counts. More serious side effects, such as lung or liver problems, can occur but are less common. Regular monitoring of blood counts, liver function, and cholesterol levels may be recommended during treatment.
Everolimus should only be used under the guidance and prescription of a qualified healthcare professional experienced in the treatment of cancer. It may interact with other medications, so it is important to inform the healthcare provider about all medications being taken, including over-the-counter drugs and supplements.
In summary, everolimus is a medication used in the treatment of certain types of cancer. It inhibits the mTOR protein to slow down cancer cell growth. Regular monitoring and adherence to healthcare provider instructions are important during everolimus treatment.
Note – The brand names and product descriptions used on this site are for informational purposes only and are the property of their respective owners.